SOCIETE DES PRODUITS NESTLE S.A. purchased 54.12M shares of AIMMUNE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $1.87B. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 10/15/2020ACC: 0000899243-20-028359
10% Owner
Since Dec 2018
+54.12M
Net shares
Net buyer
$1.87B
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
54.12M acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+43.44M
Price / share
$34.50
Trade value
$1.50B
% of position
New position
10/13/2020
0.00→43.44M
Common Stock
Indirect
Shares
+10.68M
Price / share
$34.50
Trade value
$368.52M
% of position
83.9%
10/13/2020
12.73M→23.41M
Total
Net shares
+54.12M
Net value
$1.87B
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/13/2020 | P · Purchase | +43.44M | $34.50 | $1.50B | New position | 0.00 | 43.44M |
| Common Stock Indirect | 10/13/2020 | P · Purchase | +10.68M | $34.50 | $368.52M | 83.9% | 12.73M | 23.41M |
| Total | +54.12M | $1.87B | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Series A Preferred Stock
DirectShares owned525.63K
Common Stock
DirectShares owned12.73M
Total
13.25M direct13.25M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Series A Preferred Stock | 525.63K | Direct |
| Common Stock | 12.73M | Direct |
| Total | 13.25M | 13.25M direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported